Log in to your Inderes Free account to see all free content on this page.
Herantis Pharma
1.46 EUR +2.1%4,039 investors are following this company
Revenue
-
EBIT %
-
P/E
73
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Finland
HRTIS
Daily low / high price
1.42 / 1.46
EUR
Market cap
29.43M EUR
Turnover
13.22K EUR
Volume
9.1K
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Skandinaviska Enskilda Banken | 18.6 % | 18.6 % |
Joensuun kauppa ja kone Oy | 9.8 % | 9.8 % |
Premium
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
Tone Kvåle | 25.01.2024 | 7,500EUR |
Tone Kvåle | 01.06.2022 | 7,140EUR |
Premium
This content is for our Premium customers only.
ShowingAll content types
Herantis Pharma participating at Alzheimer’s & Parkinson’s Drug Development Summit in Boston and Nordic Health Summit Japan.
Notice to Convene Herantis Pharma Plc's Annual General Meeting of Shareholders
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio